Rockville, Nov. 28, 2022 (GLOBE NEWSWIRE) -- As per a new industry analysis by Fact.MR, a market research and competitive intelligence provider, the global immunofluorescence assays market is valued at US$ 3.13 billion and is predicted to reach US$ 5.10 billion by 2033.
The particular antigen and antibody response known as immunofluorescence involves the labelling of the antibodies with a fluorescent dye and the use of a fluorescent (UV) microscope to view the antigen-antibody complex. Fluorochromes such as Acridine Orange, Rhodamine, Lissamine, and Calcofluor White are commonly employed. Specific proteins can be found in cells of specimens, cultures, tissues, microbeads and microarrays, etc., using immunofluorescence assays. Direct and indirect immunofluorescence assays are the two types of immunofluorescence assays that are typically used.
Since the antibody against the target molecule is chemically coupled to a fluorescent dye, direct immunofluorescence is less utilised to detect specific antigens. Instead, the specific antibody must be conjugated with fluorescein isothiocyanate (FITC). In an indirect immunofluorescence experiment, the second anti-immunoglobulin antibody directed against the first antibody, or secondary antibody, is tagged with a fluorescent dye while the primary antibody, which is specific for the molecule of interest, is left unlabelled. The tagged secondary antibody that is employed more commonly to detect various antigens is indirect fluorescence. However, to detect the antigen, a particular primary antibody is required.
Download a Free Sample Copy of this Report - https://www.factmr.com/connectus/sample?flag=S&rep_id=7967
Rising prevalence of chronic disorders and contagious diseases, high investments by the top market players in developing immunofluorescence techniques, and technological advancements in immunofluorescence products are driving market growth. North America and Europe dominate the global market for immunofluorescence assays due to the presence of strong market players and top-end users, as well as rising cases of chronic diseases.
Key Takeaways from Market Study
- Global demand for immunofluorescence assays is expected to increase at a CAGR of 5% from 2023-2033.
- China’s market for immunofluorescence assays is predicted to expand at a CAGR of 5% during the projected period.
- Sales of instruments are set to rise at a CAGR of 5% during the forecast period.
- Demand for reagents is predicted to expand at a CAGR of 5% during the next 10 years.
“Biotechnological and pharmaceutical companies make high use of immunofluorescence assays for disease detections and drug discoveries,” says a Fact.MR analyst.
Segments of Immunofluorescence Assays Industry Research
- By Product:
- Reagents
- Instruments
- Kits
- Antibodies
- Consumables & Accessories
- By Type:
- Indirect
- Direct
- By End User:
- Pharma & Biotech Companies
- Academic & Research Institutes
- Hospitals & Diagnostic Centers
- Contract Research Organizations
- By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Get Customization on this Report for Specific Research Solutions - https://www.factmr.com/connectus/sample?flag=RC&rep_id=7967
Winning Strategy
The immunofluorescence assays market is moderately competitive with the presence of top market players. The leading companies are highly investing in R&D for the advancements of products and techniques. The major market participants are also focusing on collaborations, partnerships, and more to increase their revenue shares.
- A 30-plex immunofluorescence panel with a focus on protein targets pertinent to immuno-oncology was created and validated by Propath UK and Nucleai in September 2022.
- Thermo Fisher Scientific Inc. acquired PeproTech in January 2022 for roughly USD 1.85 billion. Various ELISA immunofluorescence kits are among the company's offerings.
- The new Life Sciences Laboratory was estimated to be opened in Buchs, Switzerland in July 2020 by Merck KGaA, a global scientific and technological corporation. The Life Sciences Laboratory aimed was to hasten and assist analytical production, quality control, and research and development.
Key Companies Profiled
- Abcam PLC
- Bio-Rad Laboratories, Inc.
- Cell Signaling Technology, Inc.
- Danaher Corporation
- INOVA Diagnostics, Inc.
- Medipan GmbH
- MilliporeSigma
- PerkinElmer, Inc.
- Sino Biological Inc.
- Thermo Fisher Scientific, Inc.
- Vector Laboratories, Inc.
Explore Our Safe & Secure Payment Options for Quick Buy – https://www.factmr.com/checkout/7967
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global immunofluorescence assays market, presenting historical demand data (2018-2022) and forecast statistics for the period of 2023-2033.
The study divulges essential insights on the market on the basis of product (reagents, instruments, kits, antibodies, consumables & accessories), type (indirect, direct), and end user (pharma & biotech companies, academic & research institutes, hospitals & diagnostic centers, contract research organizations), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and MEA).
Check out more related studies published by Fact.MR Research:
Cell Viability Assays Market: Cell viability assays are classified strategies and technologies used to determine the strength of the cell in response to any drug tested. Cell viability assays are tested on an organ, cell, or tissue remains in cases. In general they look for the cells to find any unnatural reaction they are not supposed to follow and scale it to mark its viability.
Cell Characterization Assays Kits Market: Cell characterization assays kits are used for quantitative and qualitative analysis of cell cultures and cell line by differentiating cell populations, which work as a biomarkers for particular cell population subgroups.
Fluoro Enzymatic Assays Market: Fluoro enzymatic assays, a biochemical procedure used mainly in immunology to detect the presence of an antigen or an antibody in a sample. Fluoro enzymatic assays is used as a diagnostic tool in pathology and medicine, as well as a quality-control test across industries.
Particle-Enhanced Turbidimetric Immunoassays Market: According to the latest research by Fact.MR, Particle-Enhanced Turbidimetric Immunoassay market is set to experience significant growth during the year 2021-2031.
Lateral Flow Assays Market: The global sales of Lateral Flow Assay in 2021 was held at US$ 7.2 Bn. With 4.7%, the projected market growth during 2022 - 2032 is expected to be significantly higher than the historical growth.
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Tel: +1 (628) 251-1583
